Literature DB >> 23024589

Use of influenza vaccines in children with an egg allergy.

Charles Ps Hui, Noni E Macdonald.   

Abstract

Children are at increased risk of morbidity from influenza. Influenza vaccines are grown in eggs, leading to a minute amount of egg protein in their composition. Recent research and new practice parameters spurred by the 2009 global influenza pandemic have challenged the need to withhold influenza vaccine from patients with an egg allergy. The available data suggest that anaphylaxis from influenza vaccines is exceptionally rare, even in patients with an egg allergy. Reported allergic reactions to trivalent inactivated influenza vaccine and pH1N1 influenza vaccines have been rare; when reactions occurred, they have not caused anaphylaxis. This position statement reviews the available evidence on influenza vaccine/egg allergy-related anaphylaxis, and recommends protocols to safely administer the trivalent inactivated influenza vaccine in lower- and higher-risk children with an egg allergy.

Entities:  

Keywords:  Anaphylaxis; Egg allergy; Influenza vaccine

Year:  2011        PMID: 23024589      PMCID: PMC3202392          DOI: 10.1093/pch/16.8.491

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  4 in total

1.  Influenza vaccine recommendations for children and youth for the 2012/2013 season.

Authors:  Dorothy L Moore
Journal:  Paediatr Child Health       Date:  2012-10       Impact factor: 2.253

2.  Increasing the use of influenza vaccines in children with egg allergy.

Authors:  Charles Ps Hui
Journal:  Paediatr Child Health       Date:  2014-12       Impact factor: 2.253

3.  Influenza vaccine recommendations for children and youth for the 2011/2012 season.

Authors:  Marina I Salvadori
Journal:  Paediatr Child Health       Date:  2011-11       Impact factor: 2.253

4.  Influenza vaccine recommendations for children and youth for the 2013/2014 season.

Authors:  Dorothy L Moore
Journal:  Paediatr Child Health       Date:  2013-10       Impact factor: 2.253

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.